https://scholars.lib.ntu.edu.tw/handle/123456789/608273
標題: | In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020 | 作者: | Liu, Po-Yu Ko, Wen-Chien Lee, Wen-Sen Lu, Po-Liang Chen, Yen-Hsu Cheng, Shu-Hsing Lu, Min-Chi Lin, Chi-Ying Wu, Ting-Shu Yen, Muh-Yong Wang, Lih-Shinn Liu, Chang-Pan PEI-LAN SHAO Lee, Yu-Lin Shi, Zhi-Yuan Chen, Yao-Shen Wang, Fu-Der Tseng, Shu-Hui Lin, Chao-Nan Chen, Yu-Hui WANG-HUEI SHENG Lee, Chun-Ming Tang, Hung-Jen PO-REN HSUEH |
關鍵字: | Cefepime/enmetazobactam; Cefepime/zidebactam; Cefiderocol; Eravacycline; Omadacycline | 公開日期: | 4-九月-2021 | 來源出版物: | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 摘要: | This study aimed to investigate the in vitro susceptibilities of carbapenem-non-susceptible Pseudomonas aeruginosa (CNSPA) and Acinetobacter baumannii (CNSAB) isolates to cefiderocol, novel β-lactamase inhibitor (BLI) combinations, new tetracycline analogues, and other comparative antibiotics. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/608273 | ISSN: | 16841182 | DOI: | 10.1016/j.jmii.2021.08.012 |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。